Federal contract award
75H71022P01790
CSU FY22 THC-PHARMACY PRIORITY A MCKESSON PRIME VENDOR OPEN MARKET BUYER EARL MORRIS JR
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NAVAJO AREA INDIAN HEALTH SVC |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.0M |
| Current contract value | $1.0M |
| Potential contract value / ceiling | $1.0M |
| Start date | Aug 25, 2022 |
| Current end date | Aug 23, 2027 |
| Potential end date | Aug 23, 2027 |
| Latest award activity | Aug 26, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 26, 2025 | P00011 | $50.0K | CSU FY22 THC-PHARMACY PRIORITY A MCKESSON PRIME VENDOR OPEN MARKET BUYER EARL MORRIS JR |
| Jul 25, 2025 | P00010 | $100.0K | CSU FY22 THC-PHARMACY PRIORITY A MCKESSON PRIME VENDOR OPEN MARKET BUYER EARL MORRIS JR |
| May 29, 2025 | P00009 | $100.0K | CSU FY22 THC-PHARMACY PRIORITY A MCKESSON PRIME VENDOR OPEN MARKET BUYER EARL MORRIS JR |
| Feb 6, 2025 | P00008 | $150.0K | CSU FY22 THC-PHARMACY PRIORITY A MCKESSON PRIME VENDOR OPEN MARKET BUYER EARL MORRIS JR |
| Sep 12, 2024 | P00007 | $100.0K | CSU FY22 THC-PHARMACY PRIORITY A MCKESSON PRIME VENDOR OPEN MARKET BUYER EARL MORRIS JR |
| Nov 9, 2023 | P00006 | $50.0K | CSU FY22 THC-PHARMACY PRIORITY A MCKESSON PRIME VENDOR OPEN MARKET BUYER EARL MORRIS JR |
| Aug 25, 2023 | P00005 | $0 | CSU FY22 THC-PHARMACY PRIORITY A MCKESSON PRIME VENDOR OPEN MARKET BUYER EARL MORRIS JR |
| Aug 16, 2023 | P00004 | $150.0K | CSU FY22 THC-PHARMACY PRIORITY A MCKESSON PRIME VENDOR OPEN MARKET BUYER EARL MORRIS JR |
| Apr 11, 2023 | P00003 | $100.0K | CSU FY22 THC-PHARMACY PRIORITY A MCKESSON PRIME VENDOR OPEN MARKET BUYER EARL MORRIS JR |
| Mar 9, 2023 | P00002 | $100.0K | CSU FY22 THC-PHARMACY PRIORITY A MCKESSON PRIME VENDOR OPEN MARKET BUYER EARL MORRIS JR |
| Dec 20, 2022 | P00001 | $50.0K | CSU FY22 THC-PHARMACY PRIORITY A MCKESSON PRIME VENDOR OPEN MARKET BUYER EARL MORRIS JR |
| Aug 25, 2022 | 0 | $80.0K | CSU FY22 THC-PHARMACY PRIORITY A MCKESSON PRIME VENDOR OPEN MARKET BUYER EARL MORRIS JR |
Estimated positioning window
Oct 25, 2026 – Feb 23, 2027
65/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 65/100. Available recorded signals: 60 points.
- Contract end 2027-08-23 (302 days from calculation)
- +35 points
- 47 historical awards in this buyer and category group
- +15 points
- 12 recorded award transactions
- +10 points
- Latest award action: 2025-08-26
- +0 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.